Literature DB >> 31570879

Defining 'T cell exhaustion'.

Christian U Blank1, W Nicholas Haining2, Werner Held3, Patrick G Hogan4,5, Axel Kallies6, Enrico Lugli7, Rachel C Lynn8, Mary Philip9, Anjana Rao10,11,12, Nicholas P Restifo13, Andrea Schietinger14, Ton N Schumacher15, Pamela L Schwartzberg16, Arlene H Sharpe17, Daniel E Speiser18, E John Wherry19, Benjamin A Youngblood20, Dietmar Zehn21.   

Abstract

'T cell exhaustion' is a broad term that has been used to describe the response of T cells to chronic antigen stimulation, first in the setting of chronic viral infection but more recently in response to tumours. Understanding the features of and pathways to exhaustion has crucial implications for the success of checkpoint blockade and adoptive T cell transfer therapies. In this Viewpoint article, 18 experts in the field tell us what exhaustion means to them, ranging from complete lack of effector function to altered functionality to prevent immunopathology, with potential differences between cancer and chronic infection. Their responses highlight the dichotomy between terminally differentiated exhausted T cells that are TCF1- and the self-renewing TCF1+ population from which they derive. These TCF1+ cells are considered by some to have stem cell-like properties akin to memory T cell populations, but the developmental relationships are unclear at present. Recent studies have also highlighted an important role for the transcriptional regulator TOX in driving the epigenetic enforcement of exhaustion, but key questions remain about the potential to reverse the epigenetic programme of exhaustion and how this might affect the persistence of T cell populations.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31570879      PMCID: PMC7286441          DOI: 10.1038/s41577-019-0221-9

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  64 in total

1.  Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory.

Authors:  Grégoire Jeannet; Caroline Boudousquié; Noémie Gardiol; Joonsoo Kang; Joerg Huelsken; Werner Held
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

Review 2.  CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer.

Authors:  Laura M McLane; Mohamed S Abdel-Hakeem; E John Wherry
Journal:  Annu Rev Immunol       Date:  2019-01-24       Impact factor: 28.527

3.  The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells.

Authors:  Gustavo J Martinez; Renata M Pereira; Tarmo Äijö; Edward Y Kim; Francesco Marangoni; Matthew E Pipkin; Susan Togher; Vigo Heissmeyer; Yi Chen Zhang; Shane Crotty; Edward D Lamperti; K Mark Ansel; Thorsten R Mempel; Harri Lähdesmäki; Patrick G Hogan; Anjana Rao
Journal:  Immunity       Date:  2015-02-10       Impact factor: 31.745

4.  Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.

Authors:  Gerald Willimsky; Thomas Blankenstein
Journal:  Nature       Date:  2005-09-01       Impact factor: 49.962

5.  Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.

Authors:  Se Jin Im; Masao Hashimoto; Michael Y Gerner; Junghwa Lee; Haydn T Kissick; Matheus C Burger; Qiang Shan; J Scott Hale; Judong Lee; Tahseen H Nasti; Arlene H Sharpe; Gordon J Freeman; Ronald N Germain; Helder I Nakaya; Hai-Hui Xue; Rafi Ahmed
Journal:  Nature       Date:  2016-08-02       Impact factor: 49.962

6.  Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells.

Authors:  Bertram Bengsch; Takuya Ohtani; Omar Khan; Manu Setty; Sasikanth Manne; Shaun O'Brien; Pier Federico Gherardini; Ramin Sedaghat Herati; Alexander C Huang; Kyong-Mi Chang; Evan W Newell; Niels Bovenschen; Dana Pe'er; Steven M Albelda; E John Wherry
Journal:  Immunity       Date:  2018-05-15       Impact factor: 31.745

7.  Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers.

Authors:  Wouter Scheper; Sander Kelderman; Lorenzo F Fanchi; Carsten Linnemann; Gavin Bendle; Marije A J de Rooij; Christian Hirt; Riccardo Mezzadra; Maarten Slagter; Krijn Dijkstra; Roelof J C Kluin; Petur Snaebjornsson; Katy Milne; Brad H Nelson; Henry Zijlmans; Gemma Kenter; Emile E Voest; John B A G Haanen; Ton N Schumacher
Journal:  Nat Med       Date:  2018-12-03       Impact factor: 53.440

8.  High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors.

Authors:  Jolanda Brummelman; Emilia M C Mazza; Giorgia Alvisi; Federico S Colombo; Andrea Grilli; Joanna Mikulak; Domenico Mavilio; Marco Alloisio; Francesco Ferrari; Egesta Lopci; Pierluigi Novellis; Giulia Veronesi; Enrico Lugli
Journal:  J Exp Med       Date:  2018-08-28       Impact factor: 14.307

9.  Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice.

Authors:  Helge Frebel; Veronika Nindl; Reto A Schuepbach; Thomas Braunschweiler; Kirsten Richter; Johannes Vogel; Carsten A Wagner; Dominique Loffing-Cueni; Michael Kurrer; Burkhard Ludewig; Annette Oxenius
Journal:  J Exp Med       Date:  2012-12-10       Impact factor: 14.307

10.  Chromatin states define tumour-specific T cell dysfunction and reprogramming.

Authors:  Mary Philip; Lauren Fairchild; Liping Sun; Ellen L Horste; Steven Camara; Mojdeh Shakiba; Andrew C Scott; Agnes Viale; Peter Lauer; Taha Merghoub; Matthew D Hellmann; Jedd D Wolchok; Christina S Leslie; Andrea Schietinger
Journal:  Nature       Date:  2017-05-17       Impact factor: 49.962

View more
  282 in total

1.  Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection.

Authors:  Nina Hensel; Zuguang Gu; Dominik Wieland; Katharina Jechow; Janine Kemming; Sian Llewellyn-Lacey; Emma Gostick; Oezlem Sogukpinar; Florian Emmerich; David A Price; Bertram Bengsch; Tobias Boettler; Christoph Neumann-Haefelin; Roland Eils; Christian Conrad; Ralf Bartenschlager; Dominic Grün; Naveed Ishaque; Robert Thimme; Maike Hofmann
Journal:  Nat Immunol       Date:  2021-01-04       Impact factor: 25.606

2.  Effector and stem-like memory cell fates are imprinted in distinct lymph node niches directed by CXCR3 ligands.

Authors:  Brigette C Duckworth; Fanny Lafouresse; Verena C Wimmer; Benjamin J Broomfield; Lennard Dalit; Yannick O Alexandre; Amania A Sheikh; Raymond Z Qin; Carolina Alvarado; Lisa A Mielke; Marc Pellegrini; Scott N Mueller; Thomas Boudier; Kelly L Rogers; Joanna R Groom
Journal:  Nat Immunol       Date:  2021-03-01       Impact factor: 25.606

Review 3.  CD8+ T cell states in human cancer: insights from single-cell analysis.

Authors:  Anne M van der Leun; Daniela S Thommen; Ton N Schumacher
Journal:  Nat Rev Cancer       Date:  2020-02-05       Impact factor: 60.716

4.  CD4+ T cell exhaustion leads to adoptive transfer therapy failure which can be prevented by immune checkpoint blockade.

Authors:  Jinfei Fu; Anze Yu; Xiang Xiao; Juyu Tang; Xiongbing Zu; Wenhao Chen; Bin He
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 5.  Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.

Authors:  Mohamed A ElTanbouly; Randolph J Noelle
Journal:  Nat Rev Immunol       Date:  2020-10-19       Impact factor: 53.106

6.  Distinct peripheral blood molecular signature emerges with successful tacrolimus withdrawal in kidney transplant recipients.

Authors:  Paolo Cravedi; Miguel Fribourg; Weijia Zhang; Zhengzi Yi; Elena Zaslavsky; German Nudelman; Lisa Anderson; Susan Hartzell; Sophie Brouard; Peter S Heeger
Journal:  Am J Transplant       Date:  2020-05-27       Impact factor: 8.086

Review 7.  COVID-19: The Emerging Immunopathological Determinants for Recovery or Death.

Authors:  Tanveer Ahmad; Rituparna Chaudhuri; Mohan C Joshi; Ahmad Almatroudi; Arshad Husain Rahmani; Syed Mansoor Ali
Journal:  Front Microbiol       Date:  2020-12-01       Impact factor: 5.640

8.  Early precursor T cells establish and propagate T cell exhaustion in chronic infection.

Authors:  Daniel T Utzschneider; Sarah S Gabriel; David Chisanga; Renee Gloury; Patrick M Gubser; Ajithkumar Vasanthakumar; Wei Shi; Axel Kallies
Journal:  Nat Immunol       Date:  2020-08-24       Impact factor: 25.606

9.  Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma.

Authors:  Britney Reese; Ashok Silwal; Elizabeth Daugherity; Michael Daugherity; Mahshid Arabi; Pierce Daly; Yvonne Paterson; Layton Woolford; Alana Christie; Roy Elias; James Brugarolas; Tao Wang; Magdalena Karbowniczek; Maciej M Markiewski
Journal:  J Immunol       Date:  2020-11-06       Impact factor: 5.422

Review 10.  Immunometabolism and HIV-1 pathogenesis: food for thought.

Authors:  Asier Sáez-Cirión; Irini Sereti
Journal:  Nat Rev Immunol       Date:  2020-08-06       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.